Use access key #2 to skip to page content.
$55.88 -0.52 (-0.92%)
10/7/2008 4:01 PM

Abbott Laboratories (ABT)

CAPS Rating:
****

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.

View All Commentary (ABT)

Recs

2

Avatar drugstock2 (47.76) Submitted: 7/21/07 10:07 PM : Outperform Start Price: $52.06 ABT Score: 42.46

ABT is poised to become the next market leader in the DES market. BSX and JNJ are already loosing market share in Asia and Europe. Watch for even more growth for Humira with the new indications like treatment of Psoriasis. Margins for the diagnostic division should improve with the launch of US Prism and the discontinuation of older platforms.

Report this Post Replies: 0 | Reply

Featured Broker Partners